Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
https://www.zacks.com/stock/news/2269766/quest-diagnostics-dgx-grows-in-digital-pathology-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2269766
May 07, 2024 - Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
0
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
https://www.zacks.com/stock/news/2267265/reasons-to-retain-quest-diagnostics-dgx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2267265
May 02, 2024 - Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
0
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
https://www.zacks.com/stock/news/2255306/quest-diagnostics-dgx-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2255306
Apr 15, 2024 - Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.
0
Quest Diagnostics' (DGX) New Pact to Reduce Food Insecurity
https://www.zacks.com/stock/news/2232652/quest-diagnostics-dgx-new-pact-to-reduce-food-insecurity?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2232652
Feb 27, 2024 - Quest Diagnostics' (DGX) recent collaboration aims to advance food access and healthy eating habits for underserved communities.
0
Quest Diagnostics (DGX) Advances in Cancer Research With New Deal
https://www.zacks.com/stock/news/2216443/quest-diagnostics-dgx-advances-in-cancer-research-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216443
Jan 26, 2024 - Quest Diagnostics' (DGX) subsidiary Haystack Oncology collaborates with TriSalus Life Sciences to improve therapeutic options for aggressive forms of cancer.
0
3 Discounted MedTech Stocks Poised for Sturdy Growth in 2024
https://www.zacks.com/stock/news/2212910/3-discounted-medtech-stocks-poised-for-sturdy-growth-in-2024?cid=CS-ZC-FT-analyst_blog|industry_focus-2212910
Jan 19, 2024 - Prestige Consumer Health (PBH), Quest Diagnostics (DGX) and Hologic (HOLX) are currently at discounted zone that are expected to provide long-term gains.
0
Quest Diagnostics (DGX) Inks New Deal With Ultima Genomics
https://www.zacks.com/stock/news/2209990/quest-diagnostics-dgx-inks-new-deal-with-ultima-genomics?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209990
Jan 15, 2024 - Quest Diagnostics' (DGX) new partnership is likely to leverage its oncology expertise and national scale.
0
Quest Diagnostics (DGX) to Boost Lab Services With New Buyout
https://www.zacks.com/stock/news/2207650/quest-diagnostics-dgx-to-boost-lab-services-with-new-buyout?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207650
Jan 09, 2024 - Quest Diagnostics' (DGX) recent acquisition seeks to increase accessibility to cutting-edge, high-caliber and reasonably priced laboratory services.
0
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
https://www.zacks.com/stock/news/2205238/reasons-to-retain-quest-diagnostics-dgx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205238
Jan 03, 2024 - Investors are optimistic about Quest Diagnostics (DGX) on strength in base business and strategic collaborations.
0
Quest Diagnostics' (DGX) Haystack Oncology Inks New Deal
https://www.zacks.com/stock/news/2199231/quest-diagnostics-dgx-haystack-oncology-inks-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2199231
Dec 18, 2023 - Quest Diagnostics' (DGX) wholly owned subsidiary, Haystack Oncology, partners with the Rutgers Cancer Institute of New Jersey.
0
Pages: 12
Page 1